NASDAQ : CELZ
Creative Medical Technology Holdings, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.655 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.32M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.32M |
| Enterprise Value | -4.51M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.59M |
| Shares Outstanding | 6.59M |
| Shares Change (YoY) | +61.50% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 9.14% |
| Float | 6.56M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,439.38 |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 12.91 |
| Quick Ratio | 12.65 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -77.88% |
| Return on Assets (ROA) | -47.32% |
| Return on Invested Capital (ROIC) | -50.21% |
| Return on Capital Employed (ROCE) | -71.90% |
| Weighted Average Cost of Capital (WACC) | 14.68% |
| Revenue Per Employee | $750 |
| Profits Per Employee | -$1.51M |
| Employee Count | 4 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.90 |
| 52-Week Price Change | -82.58% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 32.01 |
| Average Volume (20 Days) | 100,287 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 82,052 |
| Short Previous Month | 164,782 |
| Short % of Shares Out | 1.24% |
| Short % of Float | 1.25% |
| Short Ratio (days to cover) | 0.08 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3,000 |
| Gross Profit | 2,006 |
| Operating Income | -6.24M |
| Pretax Income | -6.04M |
| Net Income | -6.04M |
| EBITDA | -6.13M |
| EBIT | -6.24M |
| Loss Per Share | -$1.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 8.84M |
| Total Debt | 14,194 |
| Net Cash | 8.82M |
| Net Cash Per Share | $1.34 |
| Equity (Book Value) | 8.68M |
| Book Value Per Share | 1.33 |
| Working Capital | 8.32M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.90M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 113,781 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.90M |
| FCF Per Share | -$0.90 |
Margins
| Measure | Value |
|---|
| Gross Margin | 66.87% |
| Operating Margin | -208,004.40% |
| Pretax Margin | -201,285.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -61.50% |
| Shareholder Yield | -61.50% |
| Earnings Yield | -298.22% |
| FCF Yield | -136.67% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.46 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |